Cencora Debt to Equity Ratio 2010-2024 | COR

Current and historical debt to equity ratio values for Cencora (COR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cencora debt/equity for the three months ending March 31, 2024 was 3.41.
Cencora Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $62.64B $1.23B 51.05
2023-12-31 $63.63B $1.06B 59.96
2023-09-30 $61.89B $0.67B 92.89
2023-06-30 $60.26B $0.92B 65.35
2023-03-31 $58.26B $0.51B 113.97
2022-12-31 $57.83B $0.07B 786.22
2022-09-30 $56.49B $0.07B 792.58
2022-06-30 $56.66B $0.52B 109.40
2022-03-31 $56.40B $0.91B 62.25
2021-12-31 $56.98B $0.60B 94.78
2021-09-30 $56.75B $0.58B 97.11
2021-06-30 $55.52B $0.41B 135.94
2021-03-31 $47.11B $-0.10B -458.31
2020-12-31 $46.36B $-0.51B -90.62
2020-09-30 $45.11B $-0.84B -53.73
2020-06-30 $36.82B $3.97B 9.28
2020-03-31 $38.34B $3.71B 10.35
2019-12-31 $36.95B $3.07B 12.04
2019-09-30 $36.18B $2.99B 12.09
2019-06-30 $35.37B $3.11B 11.38
2019-03-31 $35.77B $3.04B 11.77
2018-12-31 $36.10B $3.17B 11.41
2018-09-30 $34.62B $3.05B 11.35
2018-06-30 $35.03B $3.28B 10.69
2018-03-31 $35.03B $3.36B 10.42
2017-12-31 $33.49B $2.88B 11.65
2017-09-30 $33.25B $2.06B 16.11
2017-06-30 $32.10B $2.55B 12.57
2017-03-31 $31.87B $2.53B 12.60
2016-12-31 $31.80B $2.12B 15.03
2016-09-30 $31.51B $2.13B 14.80
2016-06-30 $30.04B $1.88B 15.98
2016-03-31 $30.30B $2.19B 13.83
2015-12-31 $29.46B $1.30B 22.66
2015-09-30 $27.35B $0.62B 44.37
2015-06-30 $25.76B $1.58B 16.35
2015-03-31 $25.09B $1.92B 13.09
2014-12-31 $23.14B $1.77B 13.08
2014-09-30 $19.58B $1.96B 10.00
2014-06-30 $18.64B $1.99B 9.39
2014-03-31 $18.22B $2.15B 8.49
2013-12-31 $17.55B $2.25B 7.81
2013-09-30 $16.60B $2.32B 7.16
2013-06-30 $14.16B $2.42B 5.86
2013-03-31 $13.77B $2.35B 5.87
2012-12-31 $13.16B $2.34B 5.63
2012-09-30 $12.99B $2.46B 5.29
2012-06-30 $12.82B $2.93B 4.38
2012-03-31 $12.70B $2.95B 4.31
2011-12-31 $13.07B $2.91B 4.50
2011-09-30 $12.12B $2.87B 4.23
2011-06-30 $11.65B $3.20B 3.64
2011-03-31 $11.55B $3.13B 3.69
2010-12-31 $11.17B $2.96B 3.77
2010-09-30 $11.48B $2.95B 3.89
2010-06-30 $11.07B $2.93B 3.78
2010-03-31 $10.99B $2.83B 3.88
2009-12-31 $10.82B $2.74B 3.95
2009-09-30 $10.86B $2.72B 4.00
2009-06-30 $9.95B $2.78B 3.57
2009-03-31 $9.79B $2.76B 3.55
Sector Industry Market Cap Revenue
Medical Medical Services $44.597B $262.173B
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.971B 14.14
ICON (ICLR) Ireland $27.199B 25.68
DiDi Global (DIDIY) China $17.303B 0.00
Avantor (AVTR) United States $14.163B 20.85
CochLear (CHEOY) Australia $14.103B 0.00
Viatris (VTRS) United States $14.098B 4.21
Revvity (RVTY) United States $13.345B 23.41
Medpace Holdings (MEDP) United States $13.053B 42.95
Natera (NTRA) United States $13.015B 0.00
Charles River Laboratories (CRL) United States $11.242B 21.52
Solventum (SOLV) United States $9.430B 0.00
Sonic Healthcare (SKHHY) Australia $8.373B 0.00
HealthEquity (HQY) United States $6.385B 40.99
Bausch + Lomb (BLCO) Canada $5.974B 23.92
Organon (OGN) United States $5.395B 5.12
Doximity (DOCS) United States $5.233B 36.65
PACS (PACS) United States $4.921B 0.00
Life Times (LTH) United States $4.146B 43.44
Sotera Health (SHC) United States $3.705B 18.18
Surgery Partners (SGRY) United States $3.692B 33.78
GoodRx Holdings (GDRX) United States $3.189B 121.43
Agilon Health (AGL) United States $2.834B 0.00
Progyny (PGNY) United States $2.646B 45.56
AMN Healthcare Services Inc (AMN) United States $2.167B 8.59
Premier (PINC) United States $2.051B 8.78
BrightSpring Health Services (BTSG) United States $2.004B 0.00
Alignment Healthcare (ALHC) United States $1.925B 0.00
Teladoc Health (TDOC) United States $1.542B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.251B 0.00
CareDx (CDNA) United States $0.942B 0.00
GeneDx Holdings (WGS) United States $0.831B 0.00
InnovAge Holding (INNV) United States $0.825B 0.00
Embecta (EMBC) United States $0.760B 5.16
Auna S.A (AUNA) Luxembourg $0.657B 0.00
Pediatrix Medical (MD) United States $0.633B 6.71
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Sharecare (SHCR) United States $0.497B 0.00
Enhabit (EHAB) United States $0.476B 47.45
Sonida Senior Living (SNDA) United States $0.407B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.335B 6.27
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.274B 0.00
MultiPlan (MPLN) United States $0.258B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Biodesix (BDSX) United States $0.203B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
So-Young (SY) China $0.100B 48.51
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.043B 5.82
Co-Diagnostics (CODX) United States $0.041B 0.00
Oncology Institute (TOI) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.034B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
TRxADE HEALTH (MEDS) United States $0.021B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00